WO2024141863 - ALTERNATE DESIGN OF THE EQUIPMENT USED FOR SCREENING MULTIPLE CLONES OF PRIMARY ANTIBODIES IN WESTERN BLOTTING
National phase entry is expected:
Publication Number
WO/2024/141863
Publication Date
04.07.2024
International Application No.
PCT/IB2023/062964
International Filing Date
20.12.2023
Title **
[English]
ALTERNATE DESIGN OF THE EQUIPMENT USED FOR SCREENING MULTIPLE CLONES OF PRIMARY ANTIBODIES IN WESTERN BLOTTING
[French]
CONCEPTION ALTERNÉE DE L'ÉQUIPEMENT UTILISÉ POUR LE CRIBLAGE DE MULTIPLES CLONES D'ANTICORPS PRIMAIRES DANS LE TRANSFERT DE TYPE WESTERN
Applicants **
INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED
Ground Floor, Citius, First Technology Place, No. 3, Export Promotion
Industrial Park, Whitefield
Bengaluru 560066, IN
Inventors
NARASIMHAN, Sriram
c/o Invitrogen Bioservices India Private Limited, Ground Floor, Citius, First Technology Place, No. 3, Export Promotion
Industrial Park, Whitefield
Bengaluru 560066, IN
VENUGOPAL, Vijesh
c/o iLenSys Technologies Private Limited, Plot No. 8-2-293/82/L/231/ABC, Road No 12, MLA Colony, Banjara Hills
Hyderabad 500034, IN
ARE, Srikanth Reddy
c/o iLenSys Technologies Private Limited, Plot No. 8-2-293/82/L/231/ABC, Road No 12, MLA Colony, Banjara Hills
Hyderabad 500034, IN
TANANGI, Mohith
c/o iLenSys Technologies Private Limited, Plot No. 8-2-293/82/L/231/ABC, Road No 12, MLA Colony, Banjara Hills
Hyderabad 500034, IN
Priority Data
202241077121
30.12.2022
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1426 | |
| EPO | Filing, Examination | 8146 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 3710 |
Total: 14448 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Disclosed are manifold devices for improved detection of signals during immunoassays and Western blotting methods. Embodiments of manifolds of the disclosure comprise: atop plate, the top plate comprising a plurality of open channels extending along the top plate and through the thickness of the top plate; and a bottom plate, the top plate and bottom plate being configured to engage together in an assembled configuration with a protein-containing membrane disposed therebetween such that the protein-containing membrane is accessible through the open channels of the top plate. Methods of use of manifolds for improved immunoassays are also disclosed.[French]
L'invention concerne des dispositifs collecteurs pour une détection améliorée de signaux pendant des dosages immunologiques et des procédés de transfert de type Western. Des modes de réalisation de collecteurs selon l'invention comprennent : une plaque supérieure comprenant une pluralité de canaux ouverts s'étendant le long de la plaque supérieure et à travers l'épaisseur de la plaque supérieure ; et une plaque inférieure. La plaque supérieure et la plaque inférieure sont conçues pour venir en prise ensemble dans une configuration assemblée avec une membrane contenant des protéines disposée entre celles-ci de telle sorte que la membrane contenant des protéines soit accessible à travers les canaux ouverts de la plaque supérieure. L'invention concerne également des procédés d'utilisation de collecteurs pour des dosages immunologiques améliorés.